EverythingALS has launched a new online tool called SAVA AI that uses artificial intelligence to instantly match people with amyotrophic lateral sclerosis (ALS) to clinical trials.
Fast-track status is intended to speed the development and review of treatments for serious conditions with unmet medical needs. It will allow Spinogenix to have more frequent interactions with the ...
Todd’s journey with ALS began when our children were only 9 months and 4 years old. Teaching them and preparing them for life has given us a sense of purpose in the midst of our personal pain. We’ve ...
Acurastem has received $7.5 million in funding from the California Institute for Regenerative Medicine (CIRM) to advance AS-241, its lead clinical candidate for amyotrophic lateral sclerosis (ALS) and ...
Au8, an experimental ALS therapy. CNM-Au8 has been associated with NfL reductions, a biomarker finding linked to longer ...
High-dose dazucorilant showed significant survival benefit in a Phase 2 ALS trial. It reduced mortality risk by up to 87% over two years for ALS patients. A pivotal Phase 3 trial for this ALS therapy ...
PIONEER-ALS, a clinical trial evaluating VTx-002 as a treatment for ALS, has been given a green light to launch study sites in three European nations. The therapy targets toxic TDP-43 protein clumps, ...
May is ALS Awareness Month, and in the U.S. and around the world, organizations are educating, sponsoring events, and encouraging the community to join them in taking action, providing financial ...
The data cover the first part of an ongoing Phase 1/2 clinical trial (NCT06556394), in which participants received a single injection of RAG-17 at doses ranging from 30-180 mg, or ...
The results showed that, after statistically controlling for age, 2.24 people per 100,000 in Finland died of ALS in 1987. That number rose to 4.21 people per 100,000 by 2022. This corresponded to an ...
ALS creates a significant financial burden for French families despite full heathcare coverage. Families face thousands in out-of-pocket costs. Caregivers often stop working, which adds to the ...